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INTRODUCTION 
 
Acute Renal failure is a reversible disorder. It should be detected early and 
treated promptly by correction or removal of the precipitating factor. Management 
may include conservative measures or dialysis depending on the severity of the 
renal impairment and resulting complications.  
 
Haemodialysis necessitates constant attendance of the trained professional 
and technical personnel, costly equipment heparinisation of the patients and 
surgical placement of arterial and venous catheters. At least two or three hours of 
preparations are needed before starting the dialysis, so its usage and utility is 
restricted even in the secondary centers. 
 
Peritoneal dialysis is a simple, safe, effective and relatively less expensive 
and alternative procedure in renal failure, especially acute renal failure. It does not 
require expensive instruments and trained technicians and can be performed by 
anyone at any center which can save many lives. 
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With the above considerations, the present study was undertaken to evaluate the 
efficiency and to record the complications of intermittent peritoneal dialysis in the 
management of acute renal failure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 9 
 
 
 
 
Aim of study 
 
 
 
 
  
 10 
AIMS OF THE STUDY 
 
1. To study the age and sex distribution, various clinical presentation of acute 
renal failure. 
 
2. To analyze the various etiologies of acute of renal failure. 
 
3. To analyze the complications of peritoneal dialysis 
 
4. To assess the therapeutic outcome and efficacy following peritoneal 
dialysis 
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REVIEW OF LITERATURE 
 
HISTORICAL REVIEW 
 
 
IN 1744,  The original concept of peritoneal dialysis stems from Reverem 
Stepen Hales. 
IN 1877,  The result of an animal experiment by perfusing abdominal cavity of 
rabbit with cold saline and observing the decrease of body 
temperature was published by a German investigation ‘WEGNER’1 
IN 1918,  Black-Tan and Maxcy, American pediatricians were first to utilize 
peritoneal cavity for administration of fluid to dehydrated children4. 
IN 1923,  Ganter professor of Medicine at Wuzeburg, Germany, first 
attempted peritoneal dialysis in a human being. He instilled 1.5 Liter 
physiological saline in peritoneal cavity of the patient who becomes 
acutely uremic following bilateral ureteric obstruction due to 
malignancy which resulted in transient improvement. 
IN 1937,  Housser and Werder modified Ganter’s techniques by inserting two 
catheters in the abdomen. One for in flow and other for out flow. 
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IN 19571,  Grollman was the first man to introduce intermittent peritoneal 
lavage which is the basis of technique used today2. 
IN 1959,  Maxwell and associates introduced standard commercially prepared 
solutions with sterile tube of administrations; they introduced 
flexible nylon catheter which can be easily introduced through the 
linea Alba with trochar3. 
 
Dr. Wester and Roberts made a simple modification by inserting a pointed stylet 
within a Maxwell catheter, thus eliminating the need for a trochar and sutures4. 
 
Doolan and his co-workers, Maxwell and associates contributed much to the 
improvement and perfection of techniques in peritoneal dialysis by hanging bottle 
system in late fifties and early sixties. 
IN 1968,  Tenchkoff catheter was introduced which was a major advance for 
intermittent peritoneal dialysis, and is still widely used. Now 
peritoneal dialysis evolved in to simple, machine free, power free 
natural member mediated replacement of renal function. 
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ACUTE RENAL FAILURE 
 
ACUTE RENAL FAILURE 
 
 
Acute Renal Failure is a syndrome characterized by rapid (Hours to weeks), 
decline in GFR and retention of nitrogenous waste products such as blood urea 
nitrogen and creatinine  
 
          For purpose of diagnosis and management, ARF is conveniently divided 
into three categories. 
 
CLASSIFICATION AND MAJOR DISEASE CATEGORIES CAUSING 
ACUTE RENAL FAILURE 
 
      DISEASE CATEGORY                                   PERCENTAGE OF PATIENTS  
1. Prerenal azotemia caused by acute    55 -- 60 
renal hypoperfusion 
2. Intrinsic renal azotemia caused by acute  
disease of renal parenchyma    35 -- 40 
a. Disease involving large renal vessels 
b. Disease of small renal vessels and glomeruli 
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c. Acute injury to renal tubule 
mediated by ischemia or toxins (Accounts for  
more than 90% of the cases in the intrinsic  
renal azotemic category in most series)5,6. 
 
d. Acute disease of the tubulointerstitium 
3.  Post renal azotemia caused by acute  
Obstruction of urinary collecting system. 
The diagnosis of ARF Usually hinges on serial analysis of BUN and Serum 
creatinine; though these are relatively insensitive indices of Glomerular filtration 
and several caveats must be entertained when extrapolating their levels of GFR. 
GFR may fall by 50% before the serum creatinine value rises because the initial 
decrement in creatinine filtration is matched by enhanced creatinine secretion by 
proximal tubule cells. 
 
 
 
 
 
 
 
  
 16 
ETIOLOGY OF ARF 
PRERENAL AZOTEMIA 
Prerenal azotemia is the most common cause of ARF and is an appropriate 
physiologic response to renal hypoperfusion7,8. 
By definition, the integrity of renal parenchymal tissue is maintained and GFR is 
corrected rapidly on restoration of renal perfusion and Glomerular ultrafiltration 
pressure. 
True or effective hypovolemia leads to a fall in a mean systemic arterial pressure, 
which in turn triggers arterial (eg.carotid sinus) and cardiac baroreceptors and 
initiates a series of neural and humoral responses that include activation of the 
sympathetic nervous system and renin- angiotensin- aldosterone system and 
release of antidiuretic hormone. 9,10,11,12 Nor epinephrine, angiotensin II and ADH 
act in concert in an attempt to preserve cardiac and cerebral perfusion by 
stimulating vasoconstriction in relatively non-essential vascular beds such as the 
musculocutaneous and splanchnic circulations, inhibiting salt loss through sweat 
glands, stimulating thirst and salt appetite and promoting renal salt and water 
retention. 
Glomerular perfusion, ultra filtration pressure and filtration rate are preserved 
during mild hypo perfusion through several compensatory mechanisms13. 
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Stretch receptors in the afferent arterioles in response to a reduction to perfusion 
pressure trigger relaxation of afferent arteriolar smooth muscles cells and 
vasodilatation (auto regulation) Intrarenal Biosyntesis of vasodilator prostaglandin 
(eg.Postacyclin), Prostaglandin B2) kallikrain and kinins and possible nitric oxide 
(No) is enhanced.14 - 19 
Angiotensin II may induce preferential constriction of efferent arterioles possibly 
by virtue of the increased density of angiotensin II receptors in this location20.  As 
a result renal plasma that is filtered by Glomerul filtration fraction is increased and 
GFR is maintained.  These compensatory renal responses are overwhelmed during 
states of severe hypo perfusion and ARF ensues13. Auto regulatory dilation of 
afferent arterioles is maximal at a mean systemic arterial blood pressure of about 
80mm Hg and hypo perfusion below this level is associated with a precipitous 
decline in Glomerular ultra filtration pressure and GFR. 
 
 
 
 
 
  
 18 
INTRINSIC RENAL AZOTEMIA 
DISEASES OF LARGE RENAL VESSELS. 
Occlusion of large renal vessels, either arteries or veins, is an uncommon cause of 
ARF. To affect BUN and serum creatinine, occlusion must be either bilateral or 
unilateral in patients with underlying chronic renal insufficiency or solitary 
functioning kidney. 
Renal artery may be occluded acutely by atheroemboli, thrombosis, dissection of 
aortic aneurysm, or rarely vasculitis. Atheroemboli is the most common culprits 
and are usually dislodged from an atheromatous aorta during arteriography, 
angioplasty or aortic surgery. 21,22 
Cholesterol emboli lodge in medium or small renal arteries, where they incite an 
inflammatory reaction characterized classically be intimal proliferation of vessel 
wall by macrophages and giant cells, fibrosis and irreversible occlusion of the 
vessel lumen. 23 
Thrombo emboli arise most commonly from the heart in patients with atrial 
arrythmias and produce acute infarction of renal tissue24, 25, 26.  
Renal vein thrombosis is an extremely rare cause of ARF and is usually 
encountered as a complication of nephrotic syndrome in adults or severe 
dehydration in Children27, 28, 29. 
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DISEASE OF MICRO VASCULATURE. 
Virtually all diseases that compromise blood flow within renal microvasculature 
may induce ARF. These include 
Inflammatory (eg. Glomerulonephritis and vasculitis) 
Non-inflammatory (eg.malignant Hypertension) 
Diseases of the vessel wall  
Thrombotic microangiopathies 
Hyperviscosity Syndromes 
Indeed, the decrement in renal perfusion in these settings may be severe 
enough to trigger superimposed ischemic ATN30 
Disorders of the tubulointerstitium that induce ARF, other than ischemia or tubular 
cell toxins include allergic Interstitial nephritis, severe infections, allograft 
rejection and rarely infiltrative disorders such as sarcoid, lymphoma and leukemia.  
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ACUTE TUBULAR NECROSIS 
ISCHEMIC ACUTE TUBULAR NECROSIS 
Prerenal azotemia and ischemic ATN are part of a spectrum of manifestations of 
renal hypoperfusion, prerenal azotemia being a response to mild to moderate 
hypoperfusion and ischemic ATN being the results of more severe or prolonged 
hypoperfusion often coexist with other renal insults (eg.nephrotoxins or sepsis).  
ATN is associated with injury to renal parenchyma and does not resolve 
immediately on restoration of renal perfusion. 
NEPHROTOXIC ACUTE TUBULAR NECROSIS 
It complicates the administration of many structurally diverse pharmacologic 
agents and poisons31.  In General nephrotoxins cause renal injury by inducing a 
varying combination of intrarenal vasoconstriction, tubule toxicity, and or 
intratubular obstruction.  The kidney is particulary vulnerable to nephrotoxic renal 
injury by virtue of its rich blood supply (25% of cardiac output) and its ability to 
concentrate toxins  to high levels within the medullary interstitium (via the renal 
counter current mechanism and renal epithelial cells (via specific transporters) 31. 
In addition the kidney is an important site for xenobiotic metabolism and may 
transform parent compounds into relatively harmless metabolites 31. 
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The nephrotoxic potential of most agents is dramatically increased in the presence 
of border line or overt renal ischemia, sepsis or other insults. 
POST RENAL AZOTEMIA 
Urinary tract obstruction accounts for less than 5% of the cases. ARF resulting 
from obstruction requires either obstruction or urine flow between the external 
urethral meatus and bladder neck.  Bilateral ureteric obstruction, or unilateral 
ureteric obstruction in a patient with one functioning Kidney or underlying chronic 
renal insufficiency. 
During the early stages of the obstruction (hours to Days) continued glomerular 
filtration leads to increased intraluminal pressure upstream of the site of 
obstruction.  This results in gradual distension of proximal ureter, renal pelvis, and 
calyces and a fall in GFR. 
Although acute obstruction may lead to an initial modest increase in renal blood 
flow arterial vasoconstriction soon supervenes, leading to further decline in 
Glomerular filtration. 
 
 
  
 22 
PATHOPHYSIOLOGY OF ISCHEMIC ARF 
 
The cause of Ischemic ARF is typically characterized by three phases. 
1. Initiation phase (hours to days) 
2. Maintenance phase ( 1 to 2 weeks) 
3.  Recovery phase 
INITIATION PHASE 
In this phase GFR declines because 
a. Glomerular ultrafiltration pressure is reduced as a consequence of the fall 
in renal blood flow. 
b. The flow of glomerular filtrate within tubules is obstructed by casts 
comprising epithelial cells and necrotic debris derived from ischemic 
tubular epithelium 
There is back leak of glomerular filtrate through injured tubular epithelium. 
Ischemic injury is most prominent in the terminal medullary portion of the 
proximal tubular segment, pars-recta and the medullary portion of the thick 
ascending limb of the loop of henle. 
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2. MAINTENANCE PHASE 
The initiation phase is followed by a maintenance phase during which epithelial 
cell injury is established, GFR stabilities at its nadir (typically 5 to 10 ml/min) 
urine output is lowest and uremic complications arise   
Persistent intrarenal vasoconstriction, medullary ischemia triggered by 
dysregulated release of vasoactive mediators from injured endothelial cells, (eg. 
Decreased nitric oxide, increased endothelin) congestion of medullary blood 
vessels, and reperfusion injury induced by reactive oxygen species and other 
mediators derived from leukocytes damages renal parenchymal cells. 
In addition, epithelial cell injury per se may contribute to persisitant intrarenal 
vasoconstriction by a process termed tubuloglomerular feed back. 
3. RECOVERY PHASE 
It is characterized by tubule cell regeneration and a gradual return of GFR towards 
premorbid levels.  The recovery phase may be complicated by marked diuresis. 
Diuretic phase is due to excretion of retained salt and water and other solutes, 
continued use of diuretics and delayed recovery of epithelial cell function (solute 
and water reabsorption) relative to Glomerular filtration.   
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CONFIRMATORY TESTS 
The pattern of change in serum creatinine value often provides clues to the cause 
of ARF 
Serum creatinine rise 
Within 24 to 48 hrs  - in renal ischemia due to 
1. atheroembolisation 
2. radiocontrast exposure 
• Usually peaks after 3-5 d and return to normal range in 5-7 d in contrast 
nephropathy. 
• Usually peaks after 7-10 d and returns to normal in 10-14 d in ischemic ATN  
• Usually peaks after 7-10 d and frequently irreversible in atheroembolic 
disease. 
Imaging of urinary tract by plain film or abdomen ultrasonography, computed 
tomography or magnetic resonance is recommended for most patients with ARF to 
distinguish between acute and chronic renal failure and exclude acute obstructive 
uropathy32. 
Plain film of abdomen with tomography if necessary usually provides a reliable 
index of kidney size and may detect Ca ++ containing kidney stones. 
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However the capacity of ultrasonography to determine cortical thickness, 
differences in cortical and medullary density and the integrity of the collecting 
system in addition to kidney size, makes it the screening modality of choice in 
most cases of ARF33. 
Renal biopsy is useful when cause of intrinsic renal azotemia is unclear. 
MANAGEMENT 
Because there are no specific therapies for treatment of ischemic and nephrotoxic 
ARF prevention is of paramount importance. 
SPECIFIC THERAPIES 
• Prerenal azotemia is rapidly reversible upon correction of primary 
hemodynamic abnormality. 
• Postrenal azotemia – resolves upon relief of obstruction. 
• No specific therapies for ischemic or nephrotoxic ARF. Management of 
these disorders should foucus on elimination of the causative hemodynamic 
abnormality, toxin, avoidance of additional insults and prevention and 
treatment of complications. 
• Specific treatment of other causes of intrinsic renal azotemia depends on 
the underlying pathology, 
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Dialysis replaces renal function until regeneration and repair restore renal 
function. Hemodialysis and peritoneal dialysis appear equally effective for 
management of ARF. 
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PERITONEAL DIALYSIS 
Peritoneal dialysis has become a simple procedure which is now available in most 
hospitals 35, 36, 37. It is done with commercially prepared solutions and a disposable 
catheter38 is easy to set up and carries an low incidence of complications. 
STRUCTURE AND FUNCTION OF THE PERITONEAL MEMBRANE. 
A Monocellular layer of membrane lines the inner surface of the abdominal wall 
and reflects over the visceral organs, covering them and creating a space of the 
peritoneum. 
When aqueous solutions are instilled into the peritoneal cavity their solute 
composition approaches Gibbs Donnan equilibrium with plasma by diffusion 
along the electrochemical concentration gradients. This is the major mechanism of 
solute transfer during peritoneal dialysis and the rationale underlying its clinical 
use. Concurrently iso-osmotic solutions are absorbed into the circulation 
predominantly through the diaphragmatic lymphatics at a rate faster than the rate 
of ultrafiltration, which is induced by transcapillary hydrostatic pressure gradient 
alone. To achieve net ultra filtration, a slowly or non-diffusible solute must be 
added to the solution instilled into the peritoneum to serve as an osmotic agent. 
These two process, diffusion and osmotic ultrafiltration, govern peritoneal 
dialysis, although net solute and water removal are reduced by the absorption of 
solution through lymphatics. Solutes such as fatty acids typically enter peritoneal 
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dialysate through metabolic production where as others may undergo hepatic 
biotransformation during absorption. 
The volume of peritoneal dialysis solution per exchange is typically only about 5% 
of the total body water, Hence solute equilibration between plasma water and 
peritoneal dialysate occurs rather quickly. As a consequence, in order to achieve 
maximal transport per minute, the dialysate must be exchanged reasonably rapidly, 
despite a relatively low blood flow to the peritoneum. 
The peritoneal diffusion barrier consists of fluid films in the blood and in the 
dialysate, the endothelium, the mesothelium their basement membranes and the 
intervening interstitium39.  
There is evidence favoring the concept that during peritoneal dialysis solutes 
transfer through intercellular channels. Transcellular transport is not considered 
quantitatively important. It is noteworthy that dialysate potassium and sodium 
equilibrate with the concentrations in the extra cellular fluid, not with 
concentrations within cells40. 
The diffusion of large solutes is limited predominantly by the dimensions of the 
intercellular pores of the expillary wall but movement of the solutes is restricted 
by stagnant fluid films of the blood, dialysate and interstitium. The blood flow rate 
and dialysis fluid volume and exchange rate select these fluid lines to a great 
extent. Higher peritoneal blood flow rates are ordinarily accompanied by higher 
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blood volume, which should increase capillary for diffusion and also accelerating 
transport of solutes. 
GENERAL PRINCIPLES 
The peritoneal cavity is lined by a semipermeable membrance which has an area 
of about 2.2 square meters and its solutes are transferred across the membrane, 
mainly by diffusion. 
The clearance of a solute such as urea depends on a number of factors. 
EQUILIBRIUM TIME 
When fluid is introduced into the peritoneal cavity, diffusion occurs rapidly for the 
first 30 min and than more slowly for the following 2 hrs. 
RATE OF DIALYSATE FLOW 
When the flow of the dialysing fluid is increased from 1 litre to 3.5 litres / hours, 
urea clearance increases from 12 ml / min to 30 ml / min. Further increments in 
clearance may be obtained with higher flow rates41. 
TEMPERATURE 
Heating dialysis fluid from 20 to 37C causes dilatation of peritoneal vessels and 
increases urea clearance by 35%42. 
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DIALYZING FLUID 
Hypertonic solutions increase urea transport because of solvent drag and increased 
permeability of the peritoneal membrane. The use of 7% instead of 1.5% glucose 
concentration in the dialysis fluid increases urea clearance by about 50%43. 
PERMEABILITY OF THE PERITONEUM 
This increased by heat, hypertonic solutions, infections and experimentally by 
surface active agents such as dioctyl sodium sulfo succinate, Decreased 
permitability to creatinine, urate and other larger molecules may occur in the acute 
renal failure associated with heat stress and exercise44. 
INDICATIONS FOR PERITONEAL DIALYSIS45 
• Anuria or Oliguria more than 24 Hours. 
• Hyperkalemia (definitely if > 6.5 meq/l) 
• Pulmonary Edema 
• Metabolic acidosis 
• Uremic Encephalopathy 
• Uremic Pericarditis 
• Uremic Syndrome 
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• Blood area > 200mg/dl 
• Serum creatinine > 10 mg/dl 
COMPOSITION OF DIALYSATE FLUID 
The concentrations of Dextrose used are 1.5%, 2.5%, 3.5% or 4.25, 7%. The 
solution generally used is concentrations with 1.5% and 4.25% dextrose fluid. 
They can be used to remove excess of body water. 
• Sodium concentration – 132 meq/l 
• Magnesium concentration varies from 0.5 to 1.5 meq/l 
• Calcium concentration varies from 2.5 to 3.5 meq/l 
• Chloride Concentration varies from 95 to 102 meq/l 
• Lactate Concentration Varies from 35 to 40 meq/l 
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PROCEDURE: 
Peritoneal dialysis is usually done with commercially available administration sets 
and solutions and with a disposable thin stylet cannula which is inserted 
percutaneously46. 
The patient’s bladder is emptied and the patient is weighed. The cannula is 
inserted under local anaesthesia in a midline site about 2-3 inches below the 
umblicus It is helpful if the patient raises the head at the moment of insertion to 
tighten the abdominal muscles and prevent perforation of the bowel. A feeling of 
‘give’ indicates that the peritoneal cavity has been entered. The stylet is then 
removed. The cannula is advanced towards the left pelvic gutter, fixed with 
sutures and tape and connected to the dialysis bottles through ‘Y’ tube set. 
Two litres of warmed dialysate are run into the peritoneal cavity, allowed to 
remain for 30 min and drained out. The entire cycle is conveniently timed to last 
one hour for a more rapid dialysis the equilibration time may be shortened so that 
the cycle is reduced to 45 or even 30 minutes47. However this requires more fluid 
and increases costs. Dialysis time is usually limited to 48 hours. The cannula is 
then removed but may be reinserted later if necessary. 
A dialysis, fluid potassium concentration of 2 meq/l is generally used but in 
hyperkalemic patients potassium should be omitted for about 10 exchanges. 
In digitalized patients, various arrythmias may occur if the potassium level is 
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lowered too quickly and potassium concentration of 4 meq/l is therefore 
recommended. 
Hypertonic solutions (4.5 to 7% glucose) may be used to remove fluid in 
overhydrated patients. A careful record must be kept of the patient’s weight and 
the amount of fluid exchanged to prevent hypovolemia. 
During dialysis, the patient usually takes an unrestricted diet and is encouraged to 
sit in a chair. 
PERITONEAL DIALYSIS – ADVANTAGES: 
Peritoneal dialysis is a simpler technique doesn’t require qualified personnel and it 
is safe due to the absence of extra corporeal circuit.47 
Peritoneal dialysis avoids systemic heparinisation making it most desirable in 
treating patients in the immediate post operative period with severe trauma and 
recent wound.48 
It is preferred in some medical conditions like intracerebral haemorrhage and 
hyper coagulable state where again heparin is contraindicted. 49 
In Haemodialysis rapid correction of biochemical abnormalities of uremia will 
cause disequilibrium syndrome which will not occur in peritoneal dialysis.50 
Peritoneal dialysis is useful in hypotensive patients in whom perfusion of the 
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peritoneal membrane is still adequate where haemodialysis has its own risk. 
Peritoneal dialysis has provided convenient and satisfactory therapy for the 
pediatric patients.51 Access for the vascular cannulation for haemodialysis is a 
problem in children, again selection of appropriate size of haemodialysis is 
another problem in paediatric patients where peritoneal dialysis is an alternative49. 
In paediatric age group peritoneal dialysis provides easy access to peritoneal 
cavity and peritoneal surface area is larger, calculation for the amount of dialysate 
to be instilled is very simple (eg.50mil/kg for infants; 28-35ml/kg for 3-8yrs).49 
Peritoneal dialysis has excellent cardiovascular tolerance. It is beneficial in elderly 
patients also in patients with cardiovascular problems. 
In Diabetic patients simultaneous administration of the intraperitoneal insulin 
along with dialysate provide adequate control which favours usage in diabetes. 
HIV, Hepatitis B and C infection are common in patients undergoing 
haemodialysis which does not occur in peritoneal dialysis because it does not 
involve extracorporeal circulation. 
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PERITONEAL DIALYSIS-LIMITATIONS. 
It has its own limitations 
Peritoneal dialysis has limited utility for the treatment of hypercatabolic states like 
trauma patients or surgical patients who tend to have rapidly increasing plasma 
concentration of potassium, urea and posphate.52 
The usefulness is limited because of long duration for dialysis usually 24-36 hours 
in single sitting. 
Peritoneal dialysis has relative inefficiency in removing potassium and toxic 
substance52. 
Peritoneal dialysis may be difficult in post operative patients with multiple 
abdominal drains, post operative adhesions, infection, abdominal trauma, severe 
Gastero esophageal reflux, and in intestinal ileus. 
Peritoneal dialysis has also caused abdominal pain or discomfort during dialysis 
Bleeding or leakage fluid around the puncture site, catheter malfunction, 
peritonitis. Rare complications like Bowel and Bladder injury, atelectasis, 
pneumonia and purulent bronchitis53. Hypovolemia or hypervolemia, metabolic 
complications like hyperglycemia, hypokalemia, hyponateremia and lactic 
acidosis. 
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MATERIALS AND METHODS 
The study was conducted on 65 patients of acute renal failure admitted in the 
medical and nephrology wards of the Govt. stanley medical college Hospital for 
treatment from November 2005 to July 2006. 
All the patients were thoroughly evaluated by detailed history, clinical 
examination, biochemical parameters, ultrasonogram, peritoneal fluid cell count 
and culture as per preformed proforma. 
Various pre and post dialysis investigations included the following (1) total and 
differential count, haemoglobin, (2) clotting time (3) Blood urea (4) Serum 
creatinine (5) Blood sugar (6) Serum electrolytes (7) urine analysis. (8) X-ray 
chest and abdomen. 
 
SELECTION CRITERIA: 
The following criteria were used for selection of patients with acute renal failure. 
1. Rapid reduction of Glomerular filteration rate leading to sudden and 
progressive elevation of Blood Urea > 40 mg/dl and or serum creatinine 
>1.5 mg/dl. 
2. Normal sized or Enlarged Kidney revealed by ultra sonogram. 
  
 38 
3. Absence of pre existing renal disease. 
EXCLUSION CRITERIA: 
1. The patients with Bilateral contracted kidneys on ultrasonogram. 
DIAGNOSTIC CRITERIA FOR PERITONITIS. 
At least two of the three following conditions should be present. 
• Symptoms and signs of peritoneal inflammation 
• Cloudy peritoneal fluid with an elevated peritoneal fluid count (>100/ul) 
due to predominantly (>50%) neutrophils. 
• Demonstration of bacteria in the peritoneal fluid by Gramstain or 
culture. 
METHODOLOGY ADOPTED IN PERITONEAL DIALYSIS: 
The total of 84 procedures of intermittent peritoneal dialysis were performed and 
the frequency being 1 to 3 per person with duration of 24 hours per sitting. 
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PROCEDURE: 
MATERIAL REQUIRED 
• Disposable syringes with needle. 
• Mosquito artery forceps. 
• Sponge holding forceps. 
• Iodine solution 
• Sterile dressing 
• 2% Lignocaine 
• Peritoneal dialysis catheter set 
• Peritoneal dialysis infusin set 
• Needle holder with half circle cutting needle. 
• Thread and adhesive tape 
• Drip stand with two hangers 
• Heparin 
Before starting the peritonical dialysis, sample for Blood urea, sugar and serum 
creatinine and Electrolytes were taken. The patients Bladder is emptied and he is 
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weighed. Abdomen is prepared with savlon followed by iodine and spirit. 
Wrapping with sterile towel is done all around umbilicus, leaving small Infra – 
umbilical area open. Midline local anaesthesia (2%) lignocaine – 3 to 5 ml) is 
given one-inch below umbilicus upto parietal peritoneum. PD catheter and 
infusion set were opened and set was connected to the 2PD bottles. 
An Incision was made one inch below umbilicus upto parietal peritoneum. PD 
catheter is inserted through the incision. A feeling of “give” indicates that 
peritoneal cavity has been entered. The stylet of catheter is withdrawn little out so 
that sharp edge come inside the cannula and trauma to the intra abdominal 
structures will be minimal. The catheter is advanced towards the pouch of Douglas 
and the catheter fixed with sutures and connected to the dialysate bottle through Y 
tubing. 
If the calculated (35 – 50ml/kg) fluid has gone into the abdomen, the dialysate is 
drained immediately. Again the calculated dialysate is instilled into the peritoneal 
cavity and allowed for 30 minutes to stay and them drained out. This one 
exchange, likewise it is done for 24 exchanges. During the entire peritoneal 
dialysis a balance chart is maintained stating the amount of the dialysate instilled 
into the peritoneal cavity and the amount of dialysate drained at the end of each 
exchange. 
At the end of the peritoneal dialysis, dialysate, fluid from abdomen was sent for 
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cell count, culture and sensitivity. 
POST PERITONEAL DIALYSIS FOLLOWUP: 
After the peritoneal dialysis Blood Urea, Blood Sugar, Serum creatinine, Serum 
electrolytes were estimated. 
Daily blood urea, serum creatinine and serum electrolytes were done after the 
peritoneal dialysis, till clinical and biochemical parameters to become normal. 
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RESULTS AND OBSERVATIONS 
TABLE I 
AGE SEX DISTRIBUTION 
TABULAR VIEW 
 
Age in 
Years Males Females Total Percentage 
<20 4 0 4 6.67 
20 -- 40 27 7 34 56.67 
41 -- 60 13 7 20 33.33 
>60 1 1 2 3.33 
Total 45 (75%) 15(25%) 60 100 
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AGE SEX DISTRIBUTION 
GRAPHICAL VIEW 
 
69.23%
30.77%
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AGE SEX DISTRIBUTION 
GRAPHICAL VIEW 
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TABLE II 
ETIOLOGY ACUTE RENAL FAILURE 
TABULAR VIEW 
 
Etiology Of ARF Males Females Total Percentage 
Malaria 1 1 2 3.33 
Snake Bite 4 1 5 8.33 
CuSO4 10 1 11 18.33 
AGE 15 6 21 35 
AGN 8 Nil 8 13.33 
Septiceamia 3 Nil 3 5 
Leptospirosis 2 3 5 8.33 
Drug Induced 2 Nil 2 3.33 
Obstetric Nil 3 3 5 
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ETIOLOGY ACUTE RENAL FAILURE 
GRAPHICAL VIEW 
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TABLE III 
SYMPTOMS AND SIGNS – AT THE TIME OF PRESENTATION 
 
  Males Females Total Percentage 
Anuria /oliguria 45 15 60 100 
Heamorrhage 10 2 12 20 
Metabolic Acidosis 6 1 2 11.67 
Putmonary edema Nil Nil Nil Nil 
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TABLE III 
SYMPTOMS AND SIGNS – AT THE TIME OF PRESENTATION 
GRAPHICAL VIEW  
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TABLE IV 
BIOCHEMICAL CHANGES BEFORE AND AFTER PERITONEAL 
DIALYSIS 
  
Average Pre-
Dialysis 
Average Post-
Dialysis Change 
Urea 106.05 34.74 71.31 
Creatinine 6.225 1.47 4.755 
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TABLE V 
COMPLICATIONS OF PERITONEAL DIALYSIS 
 
Complications of Peritoneal 
Dialysis Number of Patients Percentage 
Heamorrhage in Peritoneal Cavity 10 16.67 
Mild 7 11.67 
Severe 3 5 
Peritonitis Nil nil  
Abdominal Pain 34 56.67 
Catheter Block 16 26.67 
Perforation of Gut Nil nil  
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TABLE V 
COMPLICATIONS OF PERITONEAL DIALYSIS 
GRAPHICAL VIEW 
16.67
56.67
26.67
Heamarrhage in Peritoneal
Cavity
Peritonitis
Abdominal Pain
Catheter Block
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TABLE VI 
DISTRIBUTION OF 60 PATIENTS WITH ACUTE RENAL 
FAILURE ON THE BASIS OF SERUM CREATININE 
  Group I (<4 mg/dl) Group II (4-7 mg/dl) Group III (>7 mg/dl) 
Total 7 33 20 
Males 4 27 14 
Number of 
Patients Females 3 6 6 
Total 41.14 38.03 37.5 
Males 35.25 37.15 34.21 
Mean Age 
(Years) Females 49 42 45.17 
Mean Creatinine 3.14 5.3 8.6 
Mean Number of PD    
Per Patient 1.29 1.39 1.45 
Mean Urea 
Concentration 75.43  103.72 125.5  
Mortality Rate Nil 18.51% 20% 
 
 
 
 
 
  
 54 
TABLE VII 
OUTCOME 
TABULAR VIEW  
Etiology Of ARF Total Group I (S) Group II (Ex) Group III (HD) 
Malaria 2 1 1 Nil 
Snake Bite 5 5 Nil Nil 
CuSO4 11 7 1 3 
AGE 21 17 3 1 
AGN 8 5 3 Nil 
Septiceamia 3 2 1 Nil 
Leptospirosis 5 3 Nil 2 
Drug Induced 2 1 Nil 1 
Obstetric 3 3 Nil Nil 
Total 60 44 (73.33%) 9 (15%) 7 (11.67 %) 
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TABLE VII 
OUTCOME 
GRAPHICAL VIEW  
44, 73%
9, 15%
7, 12%
Survived
Expired
Shifted To HD
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Analysis and 
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ANALYSIS AND DISCUSSION 
AGE AND SEX INCIDENCE 
In this study, the age of the patient varies from 15years to 65 years. The study 
group comprised 45 males and 15 females (75% and 25% respectively) 
Majority of patients belonged to age group of 20-40 years (56.67%). In the study 
by R.G.Singh etal (1982) the majority of patients for above mentioned age group 
was 66.66%. 
The predominance of the males over the females is similar to other reported series 
(Rai, loc, cit; zilleruelo et al, 1978).54 
However, Holiday et al (1971) did not find any significant sex difference.55 
ETIOLOGY 
In this study the most common etiology for Acute renal failure is acute gastro 
enteritis in 21 patients (35%) followed by copper sulphate in 11 patients (18.33%) 
Acute Glomerulonephrites in 8 patients (13.33%) Leptospirosis  and Snake Bite 
each 5 patients (8.33 %) septicaemia and obstetric causes each 3 patients (5%) and 
Malaria and drug induced in each 2 patients (3.33%) and peritoneal dialysis is not 
influenced by Biology of  Acute renal failure statistically (P>0.05.Z=0.34)-
TABLE-VII 
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SYMPTONS AND SIGNS 
In this study, oliguria is the commonest symptom present in 60 patients (100%) 
studies by R.G. Singh et al (1982) Showed oliguria in 95.2% 
 In this study, Hematuria in 12 patients (20 %) studies by R.G.Singh et al (1982) 
showed incidence of Hematuria in 52.3% 
In this study, 7 patients had clinically metabolic acidosis (11.67 %) study by R.G. 
Singh et al (1982) showed incidence of metabolic acidosis in 24% 
In this study, No patients had pulmonary edema, Study by R.G.Singh etal (1982) 
showed incidence of pulmonary edema in 14.4 %. 
 
BIOCHEMICAL CHANGES AFTER DIALYSIS. 
In this study, the average predialysis value of urea is 106.05mg% and average post 
dialysis value of urea is 34.74 mg% and change is  71.31mg%.  The average pre-
dialysis value of creatinine is 6.23mg% and the average post dialysis value of 
creatinine is 1.47mg%.  The change is 4.76mg%. 
The study by Acharya et al (1976)56 showed reduction in mean blood urea of 53.9 
mg% and reduction in mean serum creatinine of 2.3mg% 
Statiscally There is no significant relationship between rising level of Serum 
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creatinine and mortality in patients with Aute renal failure treated by IPD 
(P>0.05Z=2.4) – TableVI. 
 
INCIDENCE OF COMPLICATIONS. 
In this study 3 patients had severe and 7 patients had mild haemorrhage in the 
peritoneal cavitiy (16.67%) 
Study by K.S.Chugh et al (1975) 57 showed incidence of Haemorrhage in 
peritoneal cavity as 22.1% R.G.Singh et al(1982) found in 10% of the patients. 
Peritonitis was evidenced clinically in none of the patients 
Study by K.S.Chugh et al showed incidence of peritonitis as 4 percent. 
No peritonists was noticed in study by R.G.Singh et al. 
Study by EP. Simkin et al (1968) showed incidence of perforation of gut as 0-1-
1.3% 
Study by K.S.Chugh et al showed incidence of perforation of gut as 1.16%. There 
is no perforation of gut in our study. In our study, the commonest complication is 
Abdominal pain and discomfort which is statistically highly significant (P<0.001, 
Z=7.67) - Table-V 
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OUTCOME: 
In this study, overall survival rate was 73.3% (44 out of 60 patients) overall 
mortality rate was 15% (9 out of 60 patients), 7 patients (11.67%) had shifted from 
peritoneal dialysis to haemodialysis because of their hypercatabolic state and 
relatively slow response to peritoneal dialysis.  Six of them showed complete 
recovery, one patient expired. Patients who had serum creatinine level more than 
7mg/dl had highest mortality rate of 20% 
Study by R.G.Singh etal showed incidence of overall survival rate of 71.42%  
Study by K.S.Chugh et al showed overall survival rate of 55% 
Overall Survival rate of patients in our study in comparison to study by 
K.S.CHUGH et al is statistically highly significant (P<0.001.Z= 3.11) 
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Conclusions 
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CONCLUSION 
1. MAJORITY OF PATIENTS OF ACUTE RENAL FAILURE BELONG 
TO THE AGE GROUP OF 20-40 YEARS. 
2. THE INCIDENCE OF ARF WAS HIGHER IN MALES THAN 
FEMALES. 
3. IN THIS SERIES MOST COMMON ETIOLOGY OF ACUTE RENAL 
FAILURE IS ACUTE GASTRO ENTERITIS. 
4. THE MOST COMMON PRESENTATION OF ACUTE RENAL 
FAILURE IS OLIGURIA. 
5. THE MOST COMMON COMPLICATION OF PERITONEAL DIALYSIS 
IS ABDOMINAL DISCOMFORT AND PAIN. 
6. NO INCIDENCE OF PERFORATION OF GUT IN THIS STUDY. 
7. INTERMITTENT PERITONEAL DIALYSIS IS RELATIVELY LESS 
COSTLY, REQUIRES NO NEED OF CONSTANT ATTENDANCE OF 
TRAINED PROFESSIONAL AND TECHNICAL PERSONNEL. 
8. IN THIS SERIES THE INTERMITTENT PERITONEAL DIALYSIS HAS 
PROVED TO BE READILY AVAILABLE, SIMPLE, SAFE, AND AN 
EFFECTIVE ADJUNCT TO THE TREATMENT OF PATIENTS 
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SUFFERING FROM ACUTE RENAL FAILURE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 64 
 
 
 
Bibliography 
 
 
 
 
 
 
  
 65 
BIBLOGRAPHY 
 
1. William Drukker peritoneal dialysis a historical review in replacement of 
renal function by dialysis – III Edition by Jhon F.Maher Kluwer. Academic 
publishers P470 – 492. 
2. Grollman A. Turner LB, mclean JA: intermittent peritoneal lavage in 
nephrectomized dog and its application to the human being Arch interm. 
med. 87.379, 1951 
3. Maxwell MH. Rockney RE. kleeman CR Twiss MR : Peritoneal dialysis 
JAMA 170.917, 1959 
4. Weston RE. and Roberts M. Clinical Use of style  styletcatheter for 
peritoneal dialysis Arch interm. Med. 115.659.662, 1965. 
5. Rasmussan HH, Ibels LS : ARF multivariate analysis of causes and risk 
factors, AM J Med. 73.211, 1982 
6. Lunding M. steiness I. Thaysen JH : ARF due to tubular necrosis 
immediate prognosis and complications aeta med. Scanel 176.103, 1964. 
7. Hou SH. Bushinsky DA. Wisgh JB etal hospital acquired renal 
insufficiency: A Prospective study AM J. med 74.243, 1983. 
8. BASLOV JT. Jorgensan HE. A survey of 499 patients with acute anuric 
renal insufficiency causes treatment complications and mortality AMJ med. 
34.753, 1963. 
 
  
 66 
9. KonV, Yored A. Ishikawa I : Role of renal sympathetic nerves in mediating 
hypoperfusion of renal cortical microcirculation in experimental congestive 
heart failure and acute extracelluar fluid volume depletion J. clin invest 
76.1913, 1985. 
10. Ishikawa et al. role of angiotension II in the altered renal function of CHF. 
Circ. Res 55:669, 1984. 
11. Dostemarkl et al: Angetensin II, blockade in normal man; interaction of 
rennin and sodium in maintaining blood pressure. Kidney Int 11.197, 1977 
12. A Isonderry GA, Handleman WA, Arnold P. et al vascular effects of 
arginine vasopression fluid deprivation in the rate, J chn invest 67: 961, 
1981. 
13. Hadr KI I shikawa J. Prerenal failure. A deletrious shift from renal 
compensation to decompensation N Engl J med. 379:623, 1988. 
14. Arendshorst wj. Finnwf. Gottschalk cw; autoregulation of blood flow in the 
rare kidney AM J phisiol 228; 127, 1975 
15. Balisc Brenner BM; modulation by prostaglandin synthesis inhibitors of the 
action of exogenous angiotensin II on Glomarular ultra filtration in the rat 
Res 43:889, 1978. 
 
 
  
 67 
16. Dzan VJ, colucciws, William GH, etal: prostaglandins in sever CHF, 
relation to activation of the rennin-angiotensin system and hyponatraemia 
N Engl J med. 310:347, 1984. 
17. Oliver JA Sciacei RR, Pinto J, cannon PJ: Participation of the  
prostoplantins in the control of renal blood flow during acute reduction of 
cardiac output in the dog. J Clin invest, 67.229, 1981. 
18. Yared A Kon V, Jchikawa I : Mechanism of preservation of renal perfusion 
and filtration during acute extra cellular fluid volume depletion, importance 
of intra renal vasopressin – prostaglandin interaction for protecting kidneys 
from constrictor action of vasopressin J clin invest 75:1477, 1985. 
19. Johnson PA, Benson DB, Perrin NS, etal; control of the rat renal vascular 
resistance during alteration in sodium balance. Cife Res 48:728, 1981. 
20. Hall JE, Guyton AC, Jackson TE et al; Control of GER by the rennin 
angiotensin system AM  J, physiol, 233:1366, 1977. 
21. Retan JW, Miller RW; microembolic complications atheroselerosis. 
Literature review and report of a patient, Arch intern, med. 118:534, 1966. 
22. Thurlbeck WM, eastleman B; Atheromatous emboli to the kidneys after 
aortic surgery N. Engl, J. med 138:1430, 1978. 
 
 
 
  
 68 
23. Handler FD, Clinical and pathologic significance of atheromatous 
embolization with empasis on the etiology of renal hypertension AM J med 
20: 366, 1956. 
24. Hosie III euggins CB, Renal infraction: statistical study of two hundred and 
five cases and detailed report of an unusual case: Arch intern med. 65:587, 
1940. 
25. Perterson MF, McDonald DF, Renal embolisation J intern 100:140, 1968. 
26. Lenson RK, Johnson F, coburn JW, Kaufman JJ: Renal artery embolism; 
clinical features of 17 cases, Ann intern med 89:477, 1978. 
27. Linch F, Papers massy SG, The clinical spectrum of renal vein thrombosis 
acute and chronic AM J med 69:819, 1980. 
28. Liach F hypercoaguladilipy Renal vein thrombosis and other thrombotic 
complications of nephrotic syndrome kidney int 28:429, 1985. 
29. Cohan AH, Wang H, Bider WA, Glassock RJ, ARF due to ATN in lupus 
nephritis am soc nephrol 15:26A, 1982, Abstract. 
30. Kinsid Smith B, Beninn Wnn, Downlin JP, Ryan GB, ARF and ATN 
associated with haematuria due to glomerulonephripis. Clin nephrol 
19.206.1983. 
 
 
 
 
  
 69 
31. Bennet WM, Porter GA, Nephrotoxic ARF due to common drugs. AM J 
phosiol 241:345, 1981. 
32. Jhonson leplide JM et al;excretion urography in ARF med 1973  
33. Wistern DM, Myers GH, et al Dr. Ethmon’s clinical investigation With 
sailuder philedelphic 1977. 
34. Epsinel CH, the ferna test: use in DD of ARF JAMA 236.579, 1976. 
35. Barry KG et al, peritoneal dialysis current application and review 
developments proceedings of the 3rd International congress of nephrology 
31:288, 1966. 
36. Barry KG, and sch wartz, FD, Peritoneal dialysis pod at clinical n amer II :  
593:609, 1964. 
37. Bennet wm, GA: Endogeneous creatinine clearance as a clinical measure of 
GFR Br.med: 34:84, 1971. 
38. In inzanas JM, Brenner Bm(eds): ARF 3rd Churchill Living stone, newyork, 
1933, P133. 
39.  Gould m, Casewek MW, The laboratory diagnosis of peritonisis during 
CAPD J HOSP: infeet 7; 155-160, 1986. 
40. Bennagonar DD, eial PD associated obsestrious peritoneal in an IV 
altogether AIDS AM Kidney dis14, 154—157, 1980. 
 
  
 70 
41. Techoff H, and G and Boer ST, influence of volume and the time on 
peritoneal clearance proceedings of the European Dialysis and transplant 
association 2; 113 – 117, 1965. 
42. Gross M and Mc Donald , Effect of dialysis temperature and flow rate on 
peritoneal clearance JAMA 202—203, 303 – 305, 1907. 
43. Hexderion LW and Nelph KD, Altered permeability of the peritoneal 
membrane after using hypertonic PD fluid AC invest 902 – 1001, 1969. 
44. Nolpl KD et al; mechanic for inefficient PD in ARF associated with clean 
press assistance Ann, intern Med. 31.917, 1969. 
45. Agarwal S, Methods in dialysis Acute Peritoneal Dialysis practical aspect 
nephol 2000, 20 – 21. 
46. Anderson PJ et al: Clinical spectrum of ARF, Bennson BM, and ARF 
contemptory issues nephrology, Churchill Living stone, Newyork, 1980. 
47. Miller RH, and Tassitro CR, Peritoneal Dialysis New Engl, Med. 281, 945 
– 948. 
48. Tripuch, K.Prakash J PD in post abdominal surgery, elderly patients 
developing ARF Perit Dial Bull 1987 576. 
49. DOSA Diag – Barvo, Clinical use of peritoneal dialysis, clinical dialysis II 
edition Allem R. Nisseaop 258 – 263. 
 
 
 
  
 71 
50. Rossan SM, ‘O’ Corner K and Shuldon 3, Hemodialysis disequlibrium Brut 
Med. J2 672 – 675, 1964. 
51. Rognk VM, Pedionephrol 1991 nov 6167 : 715, 7 
52. Micheal I Sorkin, -- Peritoneal dialysis recent advances in renal medicine 
edited by Nomums J James DK, Peter Churchill Living stone P – 130. 
53. Berthyn GM Lee, HA Ruston AL and Weehood JA  Pulminary 
complications of peritoneal dialysis Lanet 275 – 78, 1966. 
54. Zillarine Andin J Germin HB and Sermin J, current concepts in dialysis and 
management 1978, Phonum press, Newyork 113. 
55. Holliday. M. A., putter DE, and Bubrin , SS Pediat clin N America 18 : 
613, 1971. 
56. Acharya, VN Patl, KR Mannan KV and Vaidya PN -- J ASS Physicians 
India 24:811, 1926. 
57. Chugh KS Bhattacharya N Amaresan, MS Sharma BK and Bansal VK J 
Ass. Physicians India 20:215, 1975. 
58. Simkin EP, wright fk. Perforting injuries of the bowel complicating 
peritoneal catherter insertion lancer 1968, 1: 64—66. 
 
PERFORMA 
EVALUATION OF INTERMITTENT PERITONEAL DIALYSIS IN THE MANAGEMENT OF RENAL ACUTE FAILURE 
 
Name:      Age:   Sex:   Occupation:    Income:  IPNo:  
Address: 
D O A:    Unit:    Case No: 
D O D:    Ward: 
 
H/O PRESENT ILLNESS: 
HO Anuria    HO Hiccup     HO Snake Bite 
HO Oliguria    HO Convulsion    HO Diarrhoea 
HO Hematura    HO Loss of consciousness   HO Vomiting 
HO Swelling of Leg   HO Hematemesis    HO Eclampsia 
HO Puffiness of face   HO Septic Abortion    HO External Haemorrhage 
HO Difficulty in breathing  HO Peripartum Haemorrhage   HO Melena 
 
PAST HISTORY 
HO Hypertension   HO D.M.     HO Pharynitis   
HO Nephrotoxic Drug Intake  Similar Previous Episodes   HO Impetigo 
HO Native Madicine Intake 
 
CLINICAL EXAMINIATION 
Weight :  Hydration:   PR:  BP:   Cellutitis:  Acidotic Breathing:  
Pallor:   Jaundior:  Level of Consciousness:  Skin Rashes:  Pedal Edema: 
Abdomen:     CVS:  RS:   CNS: 
 
INVESTIGATION 
1. Urine:  Alb:  Sug   Dep  
2. Blood  HB:  TC:   DC:  RBC: 
3. Clotting Time: 4. ECG:  5. X-Ray Chest PA View  6. X-Ray KUB Region  7. USG ABD 
 I IPD                                                                       II IPD                                                        III IPD 
BI Sugar               
BI Urea               
Sr. Creatinine               
Sr. Electrolytes               
Sodium               
Potassium               
Urine Output               
 
COMPLICATIONS 
 
Peritonitis:     Hemorrage:      
a. Symptums:    (Slight/Sever)     Blockage of Catheter 
b. Cell Count:    Abdominal Pain    Perfection of the gut 
c. Culture and Sensitivity:   
 
PATIENTS:  IMPROVED:   TAKEN FOR HD:  WORSEN:   DIED: 
 
IPD    No of Exchanges 
   Indwelling Time 
   Ironotics 
   Hypertensin 
   With or Without Heparin 
   No of PD. 
   No Of Days of Improvement 
 
 
 
 
 
MASTER TABLE 
 
 
                  
S No. Name  Age/Sex 
Cause of 
ARF Oliguria / Anuria Haematuria 
Metbolic 
Acidosis  
Purmonary 
Oedema  Urine Output  
1 Ashokan 25/M AGE + - - - 200 
2 Kajamithen 65/M AGE + - - - 250 
3 Kumar 42/M SB + - - - 50 
4 Subramani 40/M SB + - - - 100 
5 Kanagaraj 35/M SB + - - - 100 
6 Hamsha 40/F SB + - - - 200 
7 Uma Shankar 15/M SB + - - - 200 
8 Annamal 65/F AGE + - - - 200 
9 Jhonson 27/M AGN + - - - 200 
10 Nagaraj 38/M AGE + - - - 150 
11 Prabhu 17/M AGE + - + - Nil 
12 Guna Pakiam 60/F AGE + - - - 350 
13 Kupavu 50/F Malaria + + - - 100 
14 Syed Mustaf 27/M CuSo4 + - - - 250 
15 Senthil 25/M DI + - - - 150 
16 Manikam 19/M CuSo4 + + - - 200 
17 Venkatesan 25/M CuSo4 + + - - 100 
18 Gopal 25/M CuSo4 + + - - 350 
19 Elanchzhiyan 26/M Sepeticemia + - - - 250 
20 Rajagopal 48/M AGE + - - - 100 
21 Makala 27/F PS + - - - 300 
22 Shamugathai 60/F AGE + - - - 200 
23 Marimuthu 33/M AGN + - + - 100 
24 Usha 26/F Obstetric + - - - 200 
25 Shanthanam 37/M Malaria + - - - 250 
                USG/Abdomen 
  
S No. Name  
Blood 
Sugar 
Blood 
Urea Creatinine Potasium CT ECG Right Left 
No Of 
PD 
1 Ashokan 128 128 10.2 4.9 Normal Normal Normal Normal 3 
2 Kajamithen 120 78 4.8 4.7 Normal Normal Normal Normal 1 
3 Kumar 98 162 8.3 4.9 Normal Normal Normal Normal 1 
4 Subramani 90 102 5.2 5.5 Normal Normal Normal Normal 1 
5 Kanagaraj 100 80 3.6 5.2 Normal Normal Normal Normal 1 
6 Hamsha 80 135 7.8 5.7 Normal Normal Normal Normal 1 
7 Uma Shankar 135 130 5.2 5.5 Normal Normal Normal Normal 1 
8 Annamal 135 92 4.7 6.1 Normal Normal Normal Normal 1 
9 Jhonson 129 114 4.1 3.9 Normal Normal Normal Normal 1 
10 Nagaraj 136 62 4.5 4.7 Normal Normal Normal Normal 1 
11 Prabhu 124 148 4.9 5.2 Normal Normal Normal Normal 1 
12 Guna Pakiam 92 76 3.3 3.7 Normal Normal Normal Normal 1 
13 Kupavu 124 68 2.7 3.6 Normal Normal Normal Normal 2 
14 Syed Mustaf 98 96 3.8 4.9 Normal Normal Normal Normal 1 
15 Senthil 124 130 8 5.1 Normal Normal Normal Normal 1 
16 Manikam 100 128 9 5.6 Prolonged Normal Normal Normal 1 
17 Venkatesan 114 120 4.6 4.3 Normal Normal Normal Normal 1 
18 Gopal 110 120 6.3 5.1 Normal Normal Normal Normal 1 
19 Elanchzhiyan 78 106 4.5 5.6 Normal Normal Normal Normal 1 
20 Rajagopal 140 104 4.7 5.1 Normal Normal Normal Normal 2 
21 Makala 122 84 4.8 5.3 Normal Normal Normal Normal 1 
22 Shamugathai 120 120 8 4.9 Normal Normal Normal Normal 1 
23 Marimuthu 114 110 6.6 4.5 Normal Normal Normal Normal 2 
24 Usha 90 126 5.3 4.7 Normal Normal Normal Normal 1 
25 Shanthanam 130 126 5.3 4.6 Normal Normal Normal Normal 1 
 
 
 
 
 
    
    
Haemorrhage   At Discharge 
  
S No. Name  
Abdominal 
Pain 
Catheter 
Block Slight Severe Peritonitis 
Urine 
Output Urea Creatinine OutCome 
1 Nil Nil Nil Nil Nil Nil 1900 37 1.1 Improved 
2 Kajamithen + - - - Nil 2900 42 1.4 Improved 
3 Kumar + + - - Nil 2000 38 1.1 Improved 
4 Subramani - - - - Nil 1850 38 1.6 Improved 
5 Kanagaraj + + - + Nil 1900 38 1.7 Improved 
6 Hamsha + - - - Nil 1800 38 1.6 Improved 
7 Uma Shankar + + - - Nil 2000 38 1.2 Improved 
8 Annamal - - - - Nil 2000 30 1.7 Improved 
9 Jhonson + + - + Nil       Expired 
10 Nagaraj + + - - Nil 1400 30 1.2 Improved 
11 Prabhu - + - - Nil 1400 36 1.8 Improved 
12 Guna Pakiam + - - - Nil 1300 40 1.6 Improved 
13 Kupavu + - - - Nil 1800 40 2 Improved 
14 Syed Mustaf + - - - Nil 1800 38 1.2 Improved 
15 Senthil + + - + Nil       
Started 
HD 
16 Manikam + + + - Nil       Expired 
17 Venkatesan + + + - Nil 2200 34 1.3 Improved 
18 Gopal - + + - Nil       
Started 
HD 
19 Elanchzhiyan + - - - Nil 1500 30 1.1 Improved 
20 Rajagopal + - - - Nil 1600 26 1.3 Improved 
21 Makala + - - - Nil 2200 30 0.9 Improved 
22 Shamugathai + - - - Nil       Expired 
23 Marimuthu + - - - Nil       Expired 
24 Usha - - - - Nil 1450 24 0.9 Improved 
25 Shanthanam + - - - Nil       Expired 
 
 
 
 S No. Name  Age/Sex 
Cause of 
ARF 
Oliguria / 
Anuria Haematuria 
Metbolic 
Acidosis  
Purmonary 
Oedema  Urine Output  
26 Jayasing 47/M AGE + - - - 300 
27 Kasinathan 42/M AGE + - - - 150 
28 Pandian 48/M LEP + - + - 100 
29 Ramaiyah 50/M AGE + - + - 150 
30 Annadurai 53/M AGE + - - - 200 
31 Srinivasan 35/M LEP + + - - 150 
32 Velautham 45/M AGE + - - - 150 
33 
Thilagath 
Begam 45/F LEP + - - - 300 
34 Malarkodi 45/F AGE + - - - 50 
35 Lakshmanaiah 36/M CuSo4 + - - - 200 
36 Ramalingam 55/M AGE + - - - 200 
37 Senthil Kumar 20/M AGN + + - - 100 
38 Rajendran 50/M Sepeticemia + + - - 150 
39 Jayanthi 38/F AGE + - - - 750 
40 Velmurugan 32/M AGE + - - - 200 
41 Kaniyappan 35/M AGE + - + - 200 
42 Shajagan 48/M Sepeticemia + - - - 200 
43 Magesh 31/M AGE + - + - 100 
44 Meena 43/F LEP + - - - 150 
45 Shalini 37/F AGE + - - - 450 
46 Ramesh 29/M AGN + - - - 100 
47 Kannan 50/M AGE + - - - 200 
48 Shanthi 37/F CuSo4 + - - - 300 
49 Panjanathan 50/M AGE + - - - 250 
50 Dhayalan 37/M CuSo4 + - - - 250 
 
 
 
                 USG/Abdomen 
  
S No. Name  
Blood 
Sugar 
Blood 
Urea Creatinine Potasium CT ECG Right Left 
No Of 
PD 
26 Jayasing 87 74 6.6 4.5 Normal Normal Normal Normal 3 
27 Kasinathan 92 64 3.1 5.6 Normal Normal Normal Normal 1 
28 Pandian 112 126 4.3 4.8 Normal Normal Normal Normal 1 
29 Ramaiyah 110 80 6.9 4.8 Normal Normal Normal Normal 2 
30 Annadurai 135 66 5.6 4.6 Normal Normal Normal Normal 1 
31 Srinivasan 85 120 5.9 4.6 Normal Normal Normal Normal 1 
32 Velautham 85 86 5.3 4.5 Normal Normal Normal Normal 1 
33 
Thilagath 
Begam 123 130 11.3 5.1 Normal Normal Normal Normal 2 
34 Malarkodi 134 90 8.7 5.1 Normal Normal Normal Normal 2 
35 Lakshmanaiah 98 128 6.5 5.5 Normal Normal Normal Normal 1 
36 Ramalingam 134 96 7.9 4.8 Normal Normal Normal Normal 2 
37 Senthil Kumar 86 94 4.8 6.1 Normal Normal Normal Normal 1 
38 Rajendran 124 85 5.9 5 Normal Normal Normal Normal 2 
39 Jayanthi 83 110 7.1 4.5 Normal Normal Normal Normal 1 
40 Velmurugan 93 70 4.2 5.3 Normal Normal Normal Normal 2 
41 Kaniyappan 127 75 9 5.1 Normal Normal Normal Normal 1 
42 Shajagan 133 130 6.4 5.3 Normal Normal Normal Normal 2 
43 Magesh 86 146 8.2 5.1 Normal Normal Normal Normal 1 
44 Meena 132 130 7.4 4.5 Normal Normal Normal Normal 2 
45 Shalini 95 75 2.3 5.2 Normal Normal Normal Normal 1 
46 Ramesh 100 106 6.4 3.4 Normal Normal Normal Normal 2 
47 Kannan 110 80 6.4 4.1 Normal Normal Normal Normal 2 
48 Shanthi 92 60 4.1 4.9 Normal Normal Normal Normal 2 
49 Panjanathan 94 88 11.7 4.9 Normal Normal Normal Normal 1 
50 Dhayalan 120 126 6.8 5.9 Normal Normal Normal Normal 1 
 
    
    
Haemarrhage   At Discharge 
  
S No. Name  
Abdominal 
Pain 
Catheter 
Block Slight Severe Peritonitis 
Urine 
Output Urea Creatinine OutCome 
26 Jayasing + - - - Nil 1750 36 1.6 Improved 
27 Kasinathan + - - - Nil 2400 32 1.4 Improved 
28 Pandian + + + - Nil       
Started 
HD 
29 Ramaiyah + - - - Nil 2100 38 1.6 Improved 
30 Annadurai + - - - Nil 1800 38 1.7 Improved 
31 Srinivasan + - - - Nil       
Started 
HD 
32 Velautham - - - - Nil 1800 42 1.9 Improved 
33 
Thilagath 
Begam + + - - Nil 1600 32 1.6 Improved 
34 Malarkodi + + - - Nil 1800 36 1.8 Improved 
35 Lakshmanaiah - - - - Nil 1600 30 1.4 Improved 
36 Ramalingam + - - - Nil       Expired 
37 Senthil Kumar - - - - Nil       Expired 
38 Rajendran - - - - Nil       Expired 
39 Jayanthi + - - - Nil 1900 34 1.4 Improved 
40 Velmurugan - - - - Nil 1800 34 1.8 Improved 
41 Kaniyappan - - - - Nil 2400 37 1.9 Improved 
42 Shajagan - - - - Nil 1900 38 1.2 Improved 
43 Magesh - - - - Nil       Expired 
44 Meena - - - - Nil 2100 30 1.4 Improved 
45 Shalini + - - - Nil 1100 38 1.7 Improved 
46 Ramesh - - - - Nil 1900 36 1.6 Improved 
47 Kannan - - - - Nil 2300 40 1.5 Improved 
48 Shanthi - - - - Nil 2200 41 1.4 Improved 
49 Panjanathan - - - - Nil       
Started 
HD 
50 Dhayalan - + + - Nil       
Started 
HD 
 
 S No. Name  Age/Sex 
Cause of 
ARF 
Oliguria / 
Anuria Haematuria 
Metbolic 
Acidosis  
Purmonary 
Oedema  Urine Output  
51 Makilan 31/M AGE + - - - 50 
52 Dilagath 37/F Obstetric + - + - 250 
53 Tharman 37/M CuSo4 + - - - 250 
54 Vembuliraja 37/M CuSo4 + - - - 125 
55 Raman 37/M AGE + - - - 250 
56 Kanniyamal 60/F LEP + + - - 250 
57 Babu 34/M AGE + + - - 100 
58 Ashlam Basha 32/M CuSo4 + + - - 50 
59 Narashiman 27/M DI + + - - 100 
60 Mohan 37/M CuSo4 + + - - 200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                USG/Abdomen 
  
S No. Name  
Blood 
Sugar 
Blood 
Urea Creatinine Potasium CT ECG Right Left 
No Of 
PD 
51 Makilan 82 138 8.9 5.4 Normal Normal Normal Normal 2 
52 Dilagath 97 92 5.2 4.9 Normal Normal Normal Normal 1 
53 Tharman 130 146 7.7 4.4 Normal Normal Normal Normal 1 
54 Vembuliraja 127 69 3.2 4.8 Normal Normal Normal Normal 2 
55 Raman 114 148 7.7 5.4 Normal Normal Normal Normal 1 
56 Kanniyamal 107 160 6.6 3.1 Normal Normal Normal Normal 2 
57 Babu 75 130 7.6 7.2 Normal Normal Normal Normal 1 
58 Ashlam Basha 77 150 9.6 5.4 Normal Normal Normal Normal 2 
59 Narashiman 97 140 6.2 5.6 Normal Normal Normal Normal 2 
60 Mohan 104 130 7.8 5.6 Normal Normal Normal Normal 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
    
Haemarrhage 
  
At Discharge 
  
S No. Name  
Abdominal 
Pain 
Catheter 
Block Slight Severe Peritonitis Urine Output Urea Creatinine OutCome 
51 Makilan - - - - Nil 2200 36 1.4 Improved 
52 Dilagath + - - - Nil 1800 40 1.6 Improved 
53 Tharman - - - - Nil 2000 34 1.4 Improved 
54 Vembuliraja - - - - Nil 2100 36 1.6 Improved 
55 Raman - - - - Nil 2000 34 1.4 Improved 
56 Kanniyamal - + + - Nil 1800 30 1.2 Improved 
57 Babu - - - - Nil 1900 32 1.2 Improved 
58 Ashlam Basha + - - - Nil       
Started 
HD 
59 Narashiman - - - - Nil 2100 28 0.9 Improved 
60 Mohan + - - - Nil 1700 32 1.4 Improved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS 
 
 
AGE – Acute Gastro Enteritis 
SB – Snake Bite 
AGN – Acute Glomerulo Nephritis 
CuSO4 – Copper Sulphate  
CT – Clotting Time 
ECG – Electro Cardiogram 
LEP – Leptospirosis 
USG – Ultrasonogram  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
